Common Contracts
2 similar Master Collaboration Agreement contracts by ArcherDX, Inc.
IN VITRO DIAGNOSTICS MASTER COLLABORATION AGREEMENT between ASTRAZENECA UK LIMITED and ARCHERDX, INCMaster Collaboration Agreement • June 5th, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances • Delaware
This In Vitro Diagnostics Master Collaboration Agreement (this “Agreement”) is made and entered into effective as of 2020 (the “Effective Date”), by and between AstraZeneca UK Limited, a company incorporated in England under no. 03674842 whose registered office is at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, England (“AZ”), and ArcherDX, INC ., a company incorporated in Delaware whose principal office is at 2477 55th Street, Suite 202 Boulder, CO 80301, USA (“Company”). AZ and Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
IN VITRO DIAGNOSTICS MASTER COLLABORATION AGREEMENT between ASTRAZENECA UK LIMITED and ARCHERDX, INCMaster Collaboration Agreement • May 22nd, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances • Delaware
This In Vitro Diagnostics Master Collaboration Agreement (this “Agreement”) is made and entered into effective as of 2020 (the “Effective Date”), by and between AstraZeneca UK Limited, a company incorporated in England under no. 03674842 whose registered office is at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, England (“AZ”), and ArcherDX, INC ., a company incorporated in Delaware whose principal office is at 2477 55th Street, Suite 202 Boulder, CO 80301, USA (“Company”). AZ and Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
